XERS
Xeris Pharmaceuticals Inc
9.10$
+1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| -1,496.5% | -1,585.0% | -2,283.1% | -3,833.4% | -2,959.5% | -192.6% | -93.3% | -28.7% | -18.2% | 9.8% | |
| 10.8% | 11.4% | 13.0% | 39.6% | 53.9% | 3.8% | 11.5% | 8.0% | 6.2% | 4.2% | |
| 50.2% | 32.1% | 70.1% | 238.2% | 303.9% | 23.0% | 11.0% | 6.5% | 9.0% | 7.7% | |
| 54.8% | 38.1% | 70.1% | 238.2% | 303.9% | 25.2% | 11.5% | – | – | – | |
| -333.3% | 72.0% | 65.2% | 432.7% | -102.8% | 23.9% | -31.9% | -3.8% | -4.3% | -3.5% | |
| 3.3% | 45.0% | 61.3% | 40.7% | 13.9% | 2.2% | 0.5% | 1.4% | 0.4% | 0.2% | |
| -3.3% | -45.0% | -2,769.2% | -87.5% | -1,006.8% | 197.5% | 31.3% | -3.7% | 2.4% | -0.2% | |
| – | – | – | 2,229.4% | 3,513.7% | 50.6% | 133.4% | – | – | – | |
| 364.6% | 2,258.3% | 3,988.8% | -164.0% | -2.3% | -1.1% | -0.4% | -0.6% | -1.8% | -3.7% | |
| -3.0% | 2,249.4% | 1,419.9% | 2,204.3% | 3,484.2% | 207.1% | 93.2% | 0.0% | 18.8% | 0.0% | |
| 363.2% | 2,258.3% | 5,201.3% | 2,958.5% | 4,631.3% | 54.9% | 115.6% | -1.0% | 17.8% | 3.9% | |
| -1,136.6% | 628.3% | 148.9% | -962.4% | 664.2% | 59.8% | 53.6% | -33.3% | 2.0% | 13.5% | |
| -1,499.7% | -1,630.0% | -2,344.4% | -3,874.1% | -2,973.4% | -194.8% | -93.8% | -30.1% | -18.6% | 9.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.